Despite tariffs, persistent inflation worries and a challenged labor market, Charlotte continues to outpace its peers, with ...

While consumers are certainly feeling the pinch of inflation, businesses remain healthy, and community banks are leaning into their relationship‑driven model to support housing, development projects, ...

Nimble has raised $47 million in Series B financing, led by Norwest with participation from Databricks Ventures and its existing investors. The round brings total funding to $75 million and reflects ...

Himanshu Mody, Partner & Head, DEPT® India, shares insights on its latest BFSI trends report, which identifies data, user ...

MIAMI BEACH, FLORIDA / / February 12, 2026 / Diveroli Investment Group ("DIG") today announced that it has filed a Schedule 13D with the U.S. Securities and Exchange ...

NioCorp's Recent $100 Million Capital Raise Fuels Advancement of the Elk Creek Critical Minerals Project More than $500M in Gross Capital Raised ...

Home interior shoppers who want to add a bit of class to any room while having more space to put a vase, candle or book on will want to head over to Dunelm. The high street retailer has reduced the ...

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Dollar General (NYSE:DG) has agreed to a multimillion dollar legal settlement ...

Cigna Corp's Express Scripts has settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated antitrust and consumer protection laws, and agreed to changes aimed at ...

Lyndon Electric, Barton Electric and Orleans Electric are exploring closer cooperation after a winter of spiking wholesale ...

For years, many industries, from housing to travel to financial services, have quietly relied on complexity in the fine print to obscure true pricing. Pricing disclosures became increasingly opaque, ...

NEW HAVEN, Conn., February 04, 2026--(BUSINESS WIRE)--Veradermics, Incorporated ("Veradermics"), (NYSE: MANE) a dermatologist-founded, late clinical-stage biopharmaceutical company focused on ...